Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Dare Bioscience, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 28 | 30 | +2 |
| Shares | 6.51M | 12.9M | +6.42M (+98.7%) |
| Value | $5.92M | $5.97M | +$49.3K (+0.8%) |
New holders (6)
Institutions that held Dare Bioscience, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 6,470,000 | $2.99M | 0.09% |
| Jane Street Group, LLC | 25,009 | $11.5K | 0.00% |
| Two Sigma Securities, LLC | 23,477 | $10.8K | 0.00% |
| Zuckerman Investment Group, LLC | 23,060 | $10.6K | 0.00% |
| JPMorgan Chase & Co | 104 | $48 | 0.00% |
| Cornerstone Planning Group LLC | 16 | $7 | 0.00% |
Sold out (4)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 164,021 | $149.3K |
| Riggs Asset Managment Co. Inc. | 500 | $456 |
| FMR LLC | 250 | $228 |
| Royal Bank of Canada | 382 | $0 |